Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China · Delayed Price · Currency is CNY 22.28
+0.08 (0.36%)
Jul 31, 2026, 3:00 PM CST
SHA:600332 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 78,460 | 77,656 | 74,993 | 75,515 | 70,788 | 69,014 |
Revenue Growth | 5.29% | 3.55% | -0.69% | 6.68% | 2.57% | 11.90% |
Gross Profit Gross Profit Growth | 12,640 | 12,522 | 12,475 | 14,143 | 13,240 | 13,189 |
Operating Income Operating Income Growth | 3,219 | 3,203 | 3,696 | 4,796 | 4,487 | 3,970 |
Net Income Net Income Growth | 2,946 | 2,983 | 2,835 | 4,056 | 3,967 | 3,720 |
Earnings Per Share EPS Growth | 1.81 | 1.83 | 1.74 | 2.50 | 2.44 | 2.29 |
EPS Growth | 9.16% | 5.22% | -30.10% | 2.27% | 6.63% | 27.61% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Chemical Pharmaceutical Technology Chemical Pharmaceutical Technology Growth | 3,766 | 4,008 | - | - | - |
Pharmaceutical Commercial Pharmaceutical Commercial Growth | 58,169 | 54,605 | - | - | - |
Modern Chinese Medicine Modern Chinese Medicine Growth | 7,523 | 8,042 | - | - | - |
Others Others Growth | 6,478 | 7,029 | 865.4 | 820.21 | 665.25 |
Natural Beverage Natural Beverage Growth | 9,732 | 9,747 | 11,168 | 10,526 | 10,914 |
offset of business segment offset of business segment Growth | -8,011 | -8,439 | -9,356 | -8,754 | -6,321 |
Total Total Growth | 77,656 | 74,993 | 75,515 | 70,788 | 69,014 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 12,332 | 23,805 | 22,719 | 22,042 | 24,673 | 22,377 |
Total Debt Total Debt Growth | 18,448 | 15,617 | 13,897 | 11,951 | 12,038 | 9,924 |
Net Cash (Debt) Net Cash Growth | -6,117 | 8,188 | 8,823 | 10,091 | 12,635 | 12,453 |
Net Cash Growth | - | -7.20% | -12.57% | -20.14% | 1.47% | 24.99% |
Net Cash Per Share Net Cash Per Share Growth | -3.76 | 5.04 | 5.43 | 6.21 | 7.77 | 7.66 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,447 | -232.46 | 3,442 | 4,104 | 6,999 | 5,673 |
Capital Expenditures CapEx Growth | -1,238 | -1,240 | -1,128 | -1,628 | -1,384 | -1,255 |
Free Cash Flow Free Cash Flow Growth | 209.1 | -1,472 | 2,314 | 2,475 | 5,615 | 4,419 |
Free Cash Flow Growth | -87.31% | - | -6.50% | -55.92% | 27.08% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 16.11% | 16.13% | 16.63% | 18.73% | 18.70% | 19.11% |
Operating Margin | 4.10% | 4.12% | 4.93% | 6.35% | 6.34% | 5.75% |
Pretax Margin | 4.67% | 4.75% | 4.81% | 6.77% | 7.12% | 6.84% |
Profit Margin | 3.75% | 3.84% | 3.78% | 5.37% | 5.60% | 5.39% |
FCF Margin | 0.27% | -1.90% | 3.09% | 3.28% | 7.93% | 6.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.900 | 0.850 | 0.800 | 0.749 | 0.732 | 0.687 |
Dividend Per Share Growth | -43.75% | 6.25% | 6.81% | 2.32% | 6.55% | 27.69% |
Dividend Yield | 4.04% | 3.37% | 2.96% | 2.87% | 2.75% | 2.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.30 | 13.31 | 15.42 | 10.99 | 11.69 | 14.01 |
Forward PE | 11.54 | 12.97 | 13.11 | 10.47 | 12.61 | 14.55 |
P/FCF Ratio | 164.25 | - | 18.89 | 18.00 | 8.26 | 11.79 |
PS Ratio | 0.44 | 0.51 | 0.58 | 0.59 | 0.66 | 0.76 |